Form 4: TD SYNNEX Executive Sells $426K in Stock
Insider Transaction Report
TD SYNNEX Director and Hyve Solutions Executive Dennis Polk sold 3,000 shares of common stock for approximately $426,546 through a pre-arranged 10b5-1 trading plan.
Summary
- Dennis Polk, a Director and Hyve Solutions Executive at TD SYNNEX Corp (SNX), sold 3,000 shares of the company's common stock.
- The sales occurred on August 4, 2025, and were executed under a Rule 10b5-1 trading plan established on October 13, 2024.
- The shares were sold in two tranches: 300 shares at a weighted average price of $141.82 per share, and 2,700 shares at a weighted average price of $142.22 per share.
- The total value of the shares sold is approximately $426,546.
- Following these transactions, Polk's indirect beneficial ownership through a trust is 87,660 shares, and direct ownership is 35,295 shares.
Sentiment
Score: 5
Explanation: The sale was pre-planned via a 10b5-1 plan, which mitigates negative sentiment often associated with insider selling, making it a neutral event.
Positives
- Sales were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a discretionary sale based on new material non-public information.
Negatives
- A company insider, Dennis Polk, sold a significant number of shares (3,000 shares) of common stock.
Risks
- Market perception of insider selling, even if pre-planned, could lead to negative sentiment.
Future Outlook
The sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on October 13, 2024, indicating a scheduled transaction for personal financial planning.
Management Comments
- The reporting person has provided to the issuer, and undertakes to provide upon request to the SEC staff, or any security holder of the issuer, information regarding the number of shares sold at each separate price within the range.
Industry Context
This filing reports an insider stock transaction, which is a routine disclosure for publicly traded companies and does not inherently reflect broader industry trends.
Comparison to Industry Standards
- Not applicable as this filing reports an individual insider stock transaction rather than company performance metrics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | Sales were conducted under a Rule 10b5-1 trading plan adopted on October 13, 2024, which allows insiders to sell shares at a pre-determined time or price to avoid accusations of insider trading. | October 13, 2024 | Enhances transparency and provides an affirmative defense against insider trading allegations for the reporting person. |
Related Party Transactions
- The sales were executed on behalf of the Polk family trust, of which the reporting person, Dennis Polk, is a trustee.
Stakeholder Impact
- Shareholders: May perceive the insider sale as a slight negative, though mitigated by the 10b5-1 plan.
Next Steps
- The reporting person undertakes to provide information regarding the number of shares sold at each separate price within the reported range upon request.
Key Dates
| Date | Description |
|---|---|
| October 13, 2024 | Rule 10b5-1 trading plan adopted by the reporting person on behalf of the Polk family trust. |
| August 4, 2025 | Transaction date for the sale of common stock. |
| August 5, 2025 | Signature date of the Form 4 filing. |
Recommendation
holdThe filing is a routine insider transaction report (Form 4) detailing a pre-planned sale under a Rule 10b5-1 plan. Such sales are typically for personal financial planning or diversification and do not usually signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The transaction itself does not provide new information to alter a 'hold' stance.
Keywords
TD SYNNEX, SNX, Dennis Polk, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Corporate Governance, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.